Further re Agreement

3 Feb 2009 11:32



3 February 2009

PROVEXIS plc

("Provexis" or the "Company")

EXTENSION OF EXCLUSIVE FRUITFLOW® TECHNOLOGY ASSESSMENT AGREEMENT WITH THE COCA-COLA COMPANY

Provexis plc (PXS.L), which discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, announces the extension of its exclusive technology assessment agreement for its patented Fruitflow® anti-thrombotic technology with The Coca-Cola Company until 31 March 2009. 

The exclusivity agreement covers all beverages, with the exception of mini-drinks. During the assessment period both parties will continue a programme of work including commercial and regulatory assessment. 

-ends-

For further information please contact:

Stephen Moon, Chief Executive

Provexis plc Tel: 01753 752290

Tom Griffiths/Alasdair Younie Tel: 020 7012 2000

Arbuthnot Securities